상단영역
본문영역
PharmaBio HIT-Digest 목록 ( 총 : 580건)
기사목록 보기 형태
-
Boehringer Ingelheim Korea Faces Patent Cliff as Generics Surge
이미지기사 제약 Sodam Park reporter 05.07 04:08 -
ABL Bio Advances Global CNS Strategy with BBB Shuttle Platform
이미지기사 바이오 Sodam Park reporter 05.07 04:07 -
OliX Showcases Global RNAi Strategy at 2025 R&D Day
이미지기사 바이오 Sodam Park reporter 05.07 04:07 -
Lunit–SimonMed Alliance Shakes Up U.S. AI Diagnostics Market
이미지기사 ITㆍ연관산업 Sodam Park reporter 05.02 04:21 -
Samsung Biologics Signs $518mn CMO Deal with U.S. Pharma Firm
이미지기사 바이오 Sodam Park reporter 05.02 04:20 -
Korean Subsidiary With Highest Excess Dividend to HQ Revealed
이미지기사 제약 Sodam Park reporter 05.02 04:20 -
HK inno.N’s K-CAB Achieves Success in U.S. Phase 3 GERD Trials
이미지기사 제약 Sodam Park reporter 04.26 04:53 -
Moderna at a Crossroads: From Pandemic Hero to Platform Rebuilder
이미지기사 바이오 Sodam Park reporter 04.24 15:00 -
GC Biopharma Secures Record 5.94mn-Dose Flu Vaccine in Thailand
이미지기사 제약 Sodam Park reporter 04.24 14:56 -
GL PharmTech’s Recoflavone Proves Efficacy in Phase 3 Dry Eye Trial
이미지기사 제약 Sodam Park reporter 04.24 14:45 -
RadNet Acquires iCAD to Create Full-Service AI Diagnostic Platform
이미지기사 ITㆍ연관산업 Sodam Park reporter 04.19 05:04 -
Pharma Giants Stumble Post-COVID—AstraZeneca Soars
이미지기사 제약 Sodam Park reporter 04.17 18:20 -
Amgen’s Prolia Sees Price Cut with Biologics Premium Applied
이미지기사 제약 Sodam Park reporter 04.17 11:00 -
High-Cost Drugs Under Fire: NHIS Tightens Control
이미지기사 건강보험 Sodam Park reporter 04.17 10:00 -
FDA to Phase Out Animal Testing in Drug Development
이미지기사 바이오 Sodam Park reporter 04.17 09:55 -
Merck’s New Biotech Base in Daejeon: An Interview with the Director
이미지기사 바이오 Sodam Park reporter 04.17 09:45 -
Genosco Listing Rejected Over Structural Overlap with Oscotec
이미지기사 바이오 Sodam Park reporter 04.17 09:35 -
ABL Bio Targets Global Expansion of Grabody-B Platform
이미지기사 바이오 Sodam Park reporter 04.14 04:32 -
New Hope for Liver Cancer: Lee's 8 Year Journey with Cabometyx
이미지기사 의료 Sodam Park reporter 04.14 04:32 -
ABL Bio Licenses BBB Platform to GSK in $2.9 Billion Global Deal
이미지기사 바이오 Sodam Park reporter 04.14 04:31